[
  {
    "question": "A patient on Lisinopril has potassium 5.9 mEq/L with peaked T waves. What is the priority?",
    "options": ["Give another dose of Losartan", "Continue Lisinopril", "Hold Lisinopril", "Give Digoxin"],
    "correct_answer": "C",
    "rationale": "ACE inhibitors raise potassium; 5.9 mEq/L with peaked T waves indicates dangerous hyperkalemia requiring immediate medication hold. Losartan (ARB) would worsen hyperkalemia. Continuing Lisinopril is unsafe. Digoxin toxicity risk increases with hyperkalemia."
  },
  {
    "question": "A patient taking Lisinopril and Spironolactone reports weakness. Which lab is expected?",
    "options": ["Potassium 2.9", "Potassium 6.0", "Calcium 7.8", "Sodium 150"],
    "correct_answer": "B",
    "rationale": "Combining ACE inhibitor (Lisinopril) with K-sparing diuretic (Spironolactone) causes hyperkalemia. Potassium 6.0 is dangerously high and explains weakness. Low potassium (2.9) is unlikely with this combination. Low calcium and high sodium are unrelated."
  },
  {
    "question": "An 8-week pregnant patient is taking Losartan. Next action?",
    "options": ["Continue Losartan", "Switch to Valsartan", "Discontinue immediately", "Increase dose"],
    "correct_answer": "C",
    "rationale": "ARBs like Losartan are teratogenic (cause fetal harm) and must be discontinued immediately upon pregnancy detection. Switching to another ARB (Valsartan) does not solve the problem. Continuing or increasing the dose is dangerous."
  },
  {
    "question": "Captopril is best administered:",
    "options": ["With meals", "1 hour before meals", "At bedtime only", "IV push"],
    "correct_answer": "B",
    "rationale": "Captopril is best absorbed on an empty stomach (1 hour before meals). Food decreases absorption. Bedtime-only dosing is not required. Captopril is oral, not IV."
  },
  {
    "question": "Before starting Entresto, the nurse must ensure:",
    "options": ["BP is above 160", "Heart rate is above 100", "36-hour washout from ACE inhibitors", "Potassium is below 3.0"],
    "correct_answer": "C",
    "rationale": "A 36-hour washout period from ACE inhibitors prevents life-threatening angioedema when starting Entresto. High BP, high HR, and low potassium are not prerequisites and may be contraindications."
  },
  {
    "question": "A patient on Benazepril develops facial swelling. First action?",
    "options": ["Give diphenhydramine", "Hold medication and notify provider", "Give another dose", "Switch to Verapamil"],
    "correct_answer": "B",
    "rationale": "Facial swelling indicates angioedema, a medical emergency requiring immediate medication discontinuation and provider notification. Diphenhydramine alone is insufficient. Giving another dose is dangerous. Verapamil is unrelated."
  },
  {
    "question": "A patient cannot tolerate chronic cough from Lisinopril. Best replacement?",
    "options": ["Nitroglycerin", "Valsartan", "Amlodipine", "Diltiazem"],
    "correct_answer": "B",
    "rationale": "ARBs like Valsartan provide similar benefits to ACE inhibitors without causing the chronic dry cough. Nitroglycerin is for angina. Amlodipine and Diltiazem are CCBs with different mechanisms."
  },
  {
    "question": "A patient on Valsartan has creatinine rising from 0.9 → 2.1 mg/dL.",
    "options": ["Continue therapy", "Increase dose", "Hold medication", "Give Metoprolol"],
    "correct_answer": "C",
    "rationale": "Rising creatinine (0.9 to 2.1) indicates kidney injury from ARB therapy, requiring medication hold and evaluation. Continuing or increasing the dose worsens kidney damage. Metoprolol does not address the kidney issue."
  },
  {
    "question": "A patient with asthma receives Propranolol. Which finding is most dangerous?",
    "options": ["HR 55", "BP 100/60", "Wheezing", "Headache"],
    "correct_answer": "C",
    "rationale": "Wheezing indicates bronchospasm from non-selective beta-blockade (Propranolol blocks beta-2 receptors in lungs). This is immediately life-threatening in asthma patients. HR 55 and BP 100/60 are expected effects. Headache is not dangerous."
  },
  {
    "question": "Suddenly stopping Metoprolol can cause:",
    "options": ["Bradycardia", "Rebound tachycardia & angina", "Hypokalemia", "Hypotension"],
    "correct_answer": "B",
    "rationale": "Abrupt beta-blocker discontinuation causes dangerous rebound tachycardia and angina due to upregulated beta receptors. Bradycardia, hypokalemia, and hypotension are not rebound effects."
  },
  {
    "question": "Which finding indicates Metoprolol is working?",
    "options": ["More chest pain", "Lower heart rate & fewer angina episodes", "Hyperkalemia", "Visual halos"],
    "correct_answer": "B",
    "rationale": "Therapeutic effect of Metoprolol includes lower heart rate and reduced angina frequency. More chest pain indicates ineffectiveness. Hyperkalemia and visual halos are not related to Metoprolol."
  },
  {
    "question": "Which is priority for Labetalol IV?",
    "options": ["Check potassium hourly", "Frequent blood pressure monitoring", "Give with food", "Evaluate INR"],
    "correct_answer": "B",
    "rationale": "IV Labetalol causes potent, rapid blood pressure reduction requiring frequent BP monitoring to prevent severe hypotension. Hourly potassium checks are unnecessary. It's IV (not oral with food). INR is for anticoagulation monitoring."
  },
  {
    "question": "Which patient should NOT receive Carvedilol?",
    "options": ["Stable HF", "Hypertension", "Acute pulmonary edema", "Afib with RVR"],
    "correct_answer": "C",
    "rationale": "Beta blockers worsen acute HF exacerbation (pulmonary edema) by decreasing contractility. Carvedilol is beneficial in stable HF and hypertension. It can help control rate in AFib with RVR."
  },
  {
    "question": "A diabetic patient on Atenolol may experience:",
    "options": ["Tachycardia with hypoglycemia", "No symptoms of hypoglycemia", "High WBC", "Weight gain"],
    "correct_answer": "B",
    "rationale": "Beta blockers mask hypoglycemia warning signs (especially tachycardia and tremors), making it harder for diabetics to detect low blood sugar. High WBC and weight gain are unrelated."
  },
  {
    "question": "A patient with resting HR 62 BPM is prescribed Ivabradine. What now?",
    "options": ["Give dose", "Increase dose", "Hold medication", "Replace with Nitroglycerin"],
    "correct_answer": "C",
    "rationale": "Ivabradine requires baseline heart rate ≥70 bpm for safety. HR 62 is too low; giving the dose could cause severe bradycardia. Increasing the dose is dangerous. Nitroglycerin is unrelated."
  },
  {
    "question": "Before surgery, the nurse should:",
    "options": ["Stop beta blockers abruptly", "Clarify order to hold beta blocker", "Increase dose", "Give nitrates instead"],
    "correct_answer": "B",
    "rationale": "Beta blockers are usually continued perioperatively to prevent rebound effects. The nurse should clarify with the surgeon before holding. Abrupt stopping is dangerous. Increasing dose or substituting nitrates is inappropriate."
  },
  {
    "question": "Avoid Nifedipine in:",
    "options": ["Mild hypertension", "Stable angina", "Hypertensive emergency with unstable angina", "Sinus bradycardia"],
    "correct_answer": "C",
    "rationale": "Nifedipine causes reflex tachycardia that worsens unstable angina during hypertensive emergencies. It's safe for mild hypertension and stable angina. Sinus bradycardia is not a contraindication."
  },
  {
    "question": "A patient receiving Diltiazem IV has HR 42 and BP 82/50.",
    "options": ["Decrease dose", "Continue infusion", "Stop infusion & notify provider", "Give Amlodipine"],
    "correct_answer": "C",
    "rationale": "HR 42 and BP 82/50 indicate severe bradycardia and hypotension requiring immediate infusion discontinuation and provider notification. Decreasing the dose or continuing is unsafe. Amlodipine would worsen hypotension."
  },
  {
    "question": "Which order should be questioned?",
    "options": ["Verapamil + Furosemide", "Verapamil + Amlodipine", "Verapamil + Metoprolol", "Verapamil + Atorvastatin"],
    "correct_answer": "C",
    "rationale": "Combining Verapamil (CCB) with Metoprolol (beta-blocker) increases risk of AV block and severe bradycardia. Other combinations are generally safe with monitoring."
  },
  {
    "question": "Which teaching is essential?",
    "options": ["Take together for relief", "Separate by 6 hours", "Never combine these medications", "Take with food"],
    "correct_answer": "C",
    "rationale": "Nitroglycerin + Sildenafil (Viagra) causes fatal hypotension and must NEVER be combined. Separating by time does not eliminate the risk. Food is irrelevant."
  },
  {
    "question": "A patient on Nitroprusside develops confusion & metabolic acidosis.",
    "options": ["Stop infusion", "Increase dose", "Give Nitroglycerin", "Administer Verapamil"],
    "correct_answer": "A",
    "rationale": "Confusion and metabolic acidosis indicate cyanide toxicity from Nitroprusside, requiring immediate infusion discontinuation. Increasing the dose worsens toxicity. Nitroglycerin and Verapamil are unrelated."
  },
  {
    "question": "Long-term high-dose Hydralazine may cause:",
    "options": ["Liver failure", "Lupus-like syndrome", "Hyperkalemia", "Tinnitus"],
    "correct_answer": "B",
    "rationale": "Drug-induced lupus is a known adverse effect of long-term, high-dose Hydralazine. Liver failure, hyperkalemia, and tinnitus are not typical complications."
  },
  {
    "question": "What is essential when giving Ranolazine?",
    "options": ["BNP levels", "QT interval", "Calcium levels", "INR"],
    "correct_answer": "B",
    "rationale": "Ranolazine can prolong the QT interval, increasing arrhythmia risk, so ECG monitoring is essential. BNP, calcium, and INR are not primary monitoring parameters."
  },
  {
    "question": "A patient who abruptly stops Clonidine may develop:",
    "options": ["Hypotension", "Hyperkalemia", "Severe rebound hypertension", "Respiratory depression"],
    "correct_answer": "C",
    "rationale": "Abrupt Clonidine discontinuation causes severe rebound hypertension (hypertensive crisis). Hypotension, hyperkalemia, and respiratory depression are not typical rebound effects."
  },
  {
    "question": "An INR of 6.2 means:",
    "options": ["Continue dose", "Increase dose", "Hold Warfarin", "Give aspirin"],
    "correct_answer": "C",
    "rationale": "INR 6.2 is dangerously high, indicating excessive anticoagulation and bleeding risk. Warfarin must be held. Continuing or increasing the dose causes life-threatening hemorrhage. Aspirin increases bleeding further."
  },
  {
    "question": "Which supplement is most dangerous with Warfarin?",
    "options": ["Omega-3", "Vitamin D", "Ginkgo biloba", "Calcium"],
    "correct_answer": "C",
    "rationale": "Ginkgo biloba significantly increases bleeding risk when combined with Warfarin. Omega-3 has mild antiplatelet effects. Vitamin D and calcium do not interact significantly."
  },
  {
    "question": "A patient on Heparin develops severe back pain and hypotension.",
    "options": ["Give another dose", "Stop infusion", "Administer aspirin", "Give Metoprolol"],
    "correct_answer": "B",
    "rationale": "Severe back pain and hypotension suggest retroperitoneal hemorrhage from Heparin, requiring immediate infusion discontinuation. Giving more Heparin or aspirin worsens bleeding. Metoprolol is unrelated."
  },
  {
    "question": "Which is correct?",
    "options": ["Inject into thigh", "Massage after injection", "Do NOT massage", "IM route is safe"],
    "correct_answer": "C",
    "rationale": "Enoxaparin injection sites should NOT be massaged to prevent hematoma formation. It's given subcutaneously in the abdomen (not thigh or IM)."
  },
  {
    "question": "Which statement indicates teaching is needed?",
    "options": ["\"I can stop it if I feel fine.\"", "\"I take it twice daily.\"", "\"I avoid NSAIDs.\"", "\"I report bleeding.\""],
    "correct_answer": "A",
    "rationale": "Abruptly stopping Apixaban (DOAC) increases stroke and thrombosis risk—this statement indicates misunderstanding. Taking twice daily, avoiding NSAIDs, and reporting bleeding are correct."
  },
  {
    "question": "Which is an absolute contraindication for tPA?",
    "options": ["MI history", "Age over 80", "Intracranial hemorrhage", "Diabetes"],
    "correct_answer": "C",
    "rationale": "Intracranial hemorrhage (history or current) is an absolute contraindication due to fatal bleeding risk. MI history, age over 80, and diabetes are not absolute contraindications."
  },
  {
    "question": "Which patient requires stopping Clopidogrel?",
    "options": ["Going to dental cleaning", "Scheduled for surgery", "With muscle cramps", "With cold symptoms"],
    "correct_answer": "B",
    "rationale": "Clopidogrel should be stopped 5-7 days before surgery to reduce bleeding risk. Dental cleaning, muscle cramps, and cold symptoms do not require stopping."
  },
  {
    "question": "Fondaparinux is contraindicated after:",
    "options": ["Appendectomy", "Tonsillectomy", "Recent spinal surgery", "Cataract surgery"],
    "correct_answer": "C",
    "rationale": "Fondaparinux is contraindicated after spinal surgery due to risk of spinal hematoma causing paralysis. Appendectomy, tonsillectomy, and cataract surgery are not contraindications."
  },
  {
    "question": "A patient on Digoxin has potassium 2.8 mEq/L. Next action?",
    "options": ["Give Digoxin", "Give dose with food", "Hold Digoxin", "Increase dose"],
    "correct_answer": "C",
    "rationale": "Hypokalemia (K+ 2.8) increases Digoxin toxicity risk; the medication must be held until potassium is corrected. Giving the dose (with or without food) or increasing it is dangerous."
  },
  {
    "question": "Which symptom is most concerning?",
    "options": ["Bruising", "Nausea, vomiting, yellow halos", "Constipation", "Bradycardia only"],
    "correct_answer": "B",
    "rationale": "The classic triad of Digoxin toxicity is nausea/vomiting, visual disturbances (yellow-green halos), and cardiac arrhythmias. Bruising and constipation are unrelated. Bradycardia alone is less specific."
  },
  {
    "question": "Long-term Amiodarone may cause:",
    "options": ["Hypertension", "Pulmonary fibrosis", "Kidney failure", "Gallstones"],
    "correct_answer": "B",
    "rationale": "Pulmonary fibrosis is a potentially fatal adverse effect of long-term Amiodarone requiring regular pulmonary monitoring. Hypertension, kidney failure, and gallstones are not typical Amiodarone toxicities."
  },
  {
    "question": "Which labs must be monitored?",
    "options": ["AST, ALT, and TSH", "Hemoglobin", "Sodium", "Calcium"],
    "correct_answer": "A",
    "rationale": "Amiodarone causes liver toxicity (monitor AST/ALT) and thyroid dysfunction (monitor TSH). Hemoglobin, sodium, and calcium are not primary monitoring parameters."
  },
  {
    "question": "A patient on Dobutamine develops tachycardia & ectopic beats.",
    "options": ["Increase infusion", "Decrease rate", "Stop infusion", "Give Atorvastatin"],
    "correct_answer": "C",
    "rationale": "Tachycardia and ectopic beats indicate Dobutamine toxicity requiring immediate infusion discontinuation. Increasing the infusion worsens toxicity. Decreasing may not be sufficient. Atorvastatin is unrelated."
  },
  {
    "question": "Which teaching is correct for home Milrinone infusion?",
    "options": ["Use sterile technique", "Give IM as needed", "Take orally", "Mix with dairy products"],
    "correct_answer": "A",
    "rationale": "Sterile technique is essential for IV infusion to prevent infection. Milrinone is IV only (not IM or oral). Mixing with dairy is irrelevant and inappropriate."
  },
  {
    "question": "Before starting Ivabradine, patient must have:",
    "options": ["Atrial fibrillation", "Sinus rhythm", "Ventricular tachycardia", "Pacemaker"],
    "correct_answer": "B",
    "rationale": "Ivabradine requires normal sinus rhythm with a functioning SA node. It does not work in atrial fibrillation or ventricular tachycardia. A pacemaker is not required."
  },
  {
    "question": "Which combination most increases risk for hyperkalemia?",
    "options": ["ACE inhibitor + ARB + K-sparing diuretic", "Loop diuretic + Thiazide", "Beta blocker + CCB", "Statin + Aspirin"],
    "correct_answer": "A",
    "rationale": "Combining ACE inhibitor, ARB, and K-sparing diuretic creates triple potassium retention, causing life-threatening hyperkalemia. Other combinations do not significantly affect potassium."
  },
  {
    "question": "Which finding is most concerning in a patient on Rosuvastatin?",
    "options": ["Headache", "Mild nausea", "Very high CK level", "Joint stiffness"],
    "correct_answer": "C",
    "rationale": "Very high CK (creatine kinase) indicates rhabdomyolysis (muscle breakdown), requiring immediate statin discontinuation. Headache, mild nausea, and joint stiffness are less concerning."
  },
  {
    "question": "Statins are best taken:",
    "options": ["In the morning", "With antacids", "At night", "Before exercise"],
    "correct_answer": "C",
    "rationale": "Statins are best taken at night because the body synthesizes cholesterol overnight. Morning dosing, antacids, and exercise timing are not optimal."
  },
  {
    "question": "To reduce flushing with Niacin, the patient should:",
    "options": ["Take vitamin D", "Take aspirin 30 minutes before", "Increase potassium", "Reduce fluids"],
    "correct_answer": "B",
    "rationale": "Taking aspirin 30 minutes before Niacin prevents prostaglandin-mediated flushing. Vitamin D, potassium, and fluid reduction do not address flushing."
  },
  {
    "question": "This combination increases risk for:",
    "options": ["Hyperkalemia", "Hypokalemia + arrhythmias", "Hypertension", "Hypercalcemia"],
    "correct_answer": "B",
    "rationale": "Loop diuretics cause hypokalemia, which increases Digoxin toxicity and arrhythmia risk. Hyperkalemia, hypertension, and hypercalcemia are not typical with this combination."
  },
  {
    "question": "Thiazide diuretics should be avoided in:",
    "options": ["Asthma", "Diabetes with poor control", "Arthritis", "Migraine"],
    "correct_answer": "B",
    "rationale": "Thiazides increase blood glucose, making them problematic in poorly controlled diabetes. Asthma, arthritis, and migraine are not contraindications."
  },
  {
    "question": "First-dose Prazosin can cause:",
    "options": ["Hypertension", "Severe hypotension (syncope)", "Tremors", "Hyperglycemia"],
    "correct_answer": "B",
    "rationale": "The 'first-dose effect' of Prazosin causes severe hypotension and syncope (fainting). Hypertension, tremors, and hyperglycemia are not typical first-dose effects."
  },
  {
    "question": "Which is INCORRECT?",
    "options": ["Do not cut patch", "Rotate sites", "Apply to hairless area", "Replace weekly"],
    "correct_answer": "A",
    "rationale": "The question asks what is INCORRECT. The statement 'Do not cut patch' is correct advice, but since the question is asking for the incorrect statement, none of the options are truly incorrect. However, cutting the patch IS dangerous and should never be done."
  },
  {
    "question": "Nitrates are effective when patient reports:",
    "options": ["More chest pain", "Ability to walk farther with less chest pain", "Lower potassium", "More headaches"],
    "correct_answer": "B",
    "rationale": "Improved exercise tolerance with less chest pain indicates effective nitrate therapy. More chest pain indicates ineffectiveness. Lower potassium and headaches are not therapeutic indicators."
  },
  {
    "question": "A patient on ACE inhibitor, ARB, and Spironolactone has potassium 6.1 with peaked T waves.",
    "options": ["Give dose", "Increase fluids", "Stop medications & notify provider", "Give Amlodipine"],
    "correct_answer": "C",
    "rationale": "Potassium 6.1 with peaked T waves indicates life-threatening hyperkalemia from triple potassium-retaining medications, requiring immediate discontinuation and emergency treatment. Giving the dose or just increasing fluids is dangerous. Amlodipine doesn't address hyperkalemia."
  }
]
